Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [3][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as March 10, 2021, to April 15, 2025 [3]. - The allegations include that Semler Scientific failed to disclose a material investigation by the United States Department of Justice related to the False Claims Act, while discussing potential violations in hypothetical terms [3]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of SMLR during the specified timeframe are encouraged to register for the class action, with a deadline of October 28, 2025, to seek lead plaintiff status [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

Core Viewpoint - The article discusses a class action lawsuit against Semler Scientific Inc. due to alleged misleading statements and failure to disclose a DOJ investigation related to the company's QuantaFlo device, impacting investors during the specified class period [1][4]. Group 1: Company Background and Events - Semler Scientific Inc. is facing a class action lawsuit for allegedly making materially false and misleading statements regarding its business operations and the risks associated with a DOJ investigation [4]. - The company disclosed on February 28, 2025, that it had received a civil investigative demand from the DOJ regarding reimbursement claims related to its QuantaFlo device, which was not previously disclosed to investors [2][4]. - Following the announcement of a settlement agreement with the DOJ for $29.75 million on April 15, 2025, Semler's stock price fell significantly, indicating investor concern and potential financial impact [3]. Group 2: Stock Price Impact - After the February 28, 2025 disclosure, Semler's stock price dropped by $4.03, or 9.4%, closing at $38.89 per share on March 3, 2025 [3]. - Following the April 15, 2025 settlement announcement, the stock price fell by $3.40, or 9.9%, closing at $31.00 per share on April 16, 2025, further injuring investors [3]. Group 3: Legal Proceedings - The class action lawsuit allows investors who purchased Semler securities between March 10, 2021, and April 15, 2025, to file a lead plaintiff motion by October 28, 2025 [1][5]. - The lawsuit alleges that the defendants failed to disclose the DOJ investigation, which misled investors about the company's true operational risks and prospects [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. due to allegations of violations of federal securities laws, particularly concerning undisclosed investigations by the U.S. Department of Justice [4][6]. Group 1: Legal Investigation and Claims - The firm is reminding investors of the deadline on October 28, 2025, to seek the role of lead plaintiff in a federal securities class action against Semler Scientific [4]. - The complaint alleges that Semler Scientific and its executives made false or misleading statements and failed to disclose a material investigation by the DOJ regarding violations of the False Claims Act [6]. - Following the filing of its 2024 annual report, Semler Scientific's stock fell over 9% after disclosing that it had begun initial settlement discussions with the DOJ but ceased them on the same day [7]. Group 2: Investor Communication - Faruqi & Faruqi encourages investors who suffered losses in Semler Scientific to contact them directly to discuss their legal options [1][9]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Semler Scientific's conduct [9].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The Class Period for the Semler Scientific securities is from March 10, 2021, to April 15, 2025 [1]. - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these misstatements led to investor damages when the true details became public [5].

Core Points - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [3][7] - Investors who suffered losses during the class period are encouraged to contact the law firm Bragar Eagel & Squire for legal options [1][4] Allegation Details - The complaint claims that Semler Scientific failed to disclose a material investigation by the DOJ into potential violations of the False Claims Act, while discussing such violations in hypothetical terms [3] - As a result of these omissions, the defendants' public statements were deemed materially false and misleading, leading to investor damages when the true information became public [3] Next Steps - Investors who purchased or acquired Semler shares and experienced losses are invited to reach out to the law firm for more information or to discuss their rights [4][7] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The Class Period for the Semler Scientific securities is from March 10, 2021, to April 15, 2025 [1]. - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these misstatements led to investor damages when the true details became public [5].

Core Points - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act [3][7] - The lawsuit claims that investors who purchased Semler securities between March 10, 2021, and April 15, 2025, suffered damages when the true details of the investigation were revealed [3][7] Allegation Details - The complaint alleges that Semler Scientific failed to disclose a material investigation by the DOJ while discussing potential violations of the False Claims Act in hypothetical terms [3] - Defendants' public statements were claimed to be materially false and misleading throughout the class period [3] Next Steps - Investors who acquired Semler shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information regarding their rights and potential claims [4][7] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these actions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. due to alleged violations of federal securities laws, particularly concerning undisclosed investigations by the DOJ and misleading public statements [1][2]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Semler Scientific between March 10, 2021, and April 15, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Semler Scientific, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [1][4]. - The complaint alleges that Semler Scientific and its executives failed to disclose a material investigation by the DOJ regarding violations of the False Claims Act [2]. Group 2: Financial Impact and Stock Performance - Semler Scientific's 2024 annual report revealed that initial settlement discussions with the DOJ began on February 11, 2025, but were ceased on the same day, indicating potential risks of a civil lawsuit [3]. - Following the disclosure of the DOJ investigation, Semler Scientific's stock fell over 9% on the next trading day [3]. Group 3: Participation and Whistleblower Information - Any member of the putative class can move the court to serve as lead plaintiff or remain an absent class member, with no impact on their ability to share in any recovery [4]. - The firm encourages whistleblowers, former employees, and shareholders with information regarding Semler Scientific's conduct to come forward [4].

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...